| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3532804
[patent_doc_number] => 05480375
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-02
[patent_title] => 'Pain relieving adjustable leg support'
[patent_app_type] => 1
[patent_app_number] => 8/260244
[patent_app_country] => US
[patent_app_date] => 1994-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 944
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 304
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/480/05480375.pdf
[firstpage_image] =>[orig_patent_app_number] => 260244
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/260244 | Pain relieving adjustable leg support | Jun 13, 1994 | Issued |
Array
(
[id] => 4045649
[patent_doc_number] => 05874556
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-02-23
[patent_title] => 'Hybrid genes for use in the production of T.sub.H -independent cytotoxic T cells'
[patent_app_type] => 1
[patent_app_number] => 8/244548
[patent_app_country] => US
[patent_app_date] => 1994-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 22628
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/874/05874556.pdf
[firstpage_image] =>[orig_patent_app_number] => 244548
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/244548 | Hybrid genes for use in the production of T.sub.H -independent cytotoxic T cells | Jun 5, 1994 | Issued |
| 08/213446 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISORDERS OFTHE ANTERIOR EYE | Mar 14, 1994 | Abandoned |
Array
(
[id] => 3548891
[patent_doc_number] => 05545723
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-13
[patent_title] => 'Muteins of IFN-.beta.'
[patent_app_type] => 1
[patent_app_number] => 8/213448
[patent_app_country] => US
[patent_app_date] => 1994-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 5922
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/545/05545723.pdf
[firstpage_image] =>[orig_patent_app_number] => 213448
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/213448 | Muteins of IFN-.beta. | Mar 14, 1994 | Issued |
Array
(
[id] => 4352271
[patent_doc_number] => 06218148
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-17
[patent_title] => 'DNS encoding stem cell factor'
[patent_app_type] => 1
[patent_app_number] => 8/172329
[patent_app_country] => US
[patent_app_date] => 1993-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 118
[patent_figures_cnt] => 109
[patent_no_of_words] => 53311
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/218/06218148.pdf
[firstpage_image] =>[orig_patent_app_number] => 172329
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/172329 | DNS encoding stem cell factor | Dec 20, 1993 | Issued |
| 08/161692 | IDENTIFICATION OF NOVEL SUBSTRATES | Dec 2, 1993 | Abandoned |
Array
(
[id] => 3105471
[patent_doc_number] => 05418135
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-05-23
[patent_title] => 'Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists'
[patent_app_type] => 1
[patent_app_number] => 8/095898
[patent_app_country] => US
[patent_app_date] => 1993-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 10
[patent_no_of_words] => 6790
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/418/05418135.pdf
[firstpage_image] =>[orig_patent_app_number] => 095898
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/095898 | Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists | Jul 20, 1993 | Issued |
Array
(
[id] => 3029884
[patent_doc_number] => 05349053
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-20
[patent_title] => 'Chimeric ligand/immunoglobulin molecules and their uses'
[patent_app_type] => 1
[patent_app_number] => 8/076263
[patent_app_country] => US
[patent_app_date] => 1993-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8028
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/349/05349053.pdf
[firstpage_image] =>[orig_patent_app_number] => 076263
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/076263 | Chimeric ligand/immunoglobulin molecules and their uses | Jun 9, 1993 | Issued |
Array
(
[id] => 4124001
[patent_doc_number] => 06127169
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-03
[patent_title] => 'Non-agglutinating .beta.-galactoside binding protein and its encoding nucleic acid'
[patent_app_type] => 1
[patent_app_number] => 8/050259
[patent_app_country] => US
[patent_app_date] => 1993-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 25
[patent_no_of_words] => 11272
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/127/06127169.pdf
[firstpage_image] =>[orig_patent_app_number] => 050259
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/050259 | Non-agglutinating .beta.-galactoside binding protein and its encoding nucleic acid | Apr 29, 1993 | Issued |
| 08/033996 | METHOD OF REDUCING IMMUNOGLOBULIN E RESPONSE | Mar 18, 1993 | Pending |
Array
(
[id] => 3011113
[patent_doc_number] => 05340573
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-08-23
[patent_title] => 'Method for reducing cholesterol by co-administering M-CSF and conventional cholesterol reducing agents'
[patent_app_type] => 1
[patent_app_number] => 8/027918
[patent_app_country] => US
[patent_app_date] => 1993-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1596
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/340/05340573.pdf
[firstpage_image] =>[orig_patent_app_number] => 027918
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/027918 | Method for reducing cholesterol by co-administering M-CSF and conventional cholesterol reducing agents | Mar 7, 1993 | Issued |
| 08/027601 | HUMAN INTERLEUKIN-4 PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE | Mar 4, 1993 | Abandoned |
Array
(
[id] => 3077267
[patent_doc_number] => 05296592
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-22
[patent_title] => 'Process for purifying interleukin-1 receptors'
[patent_app_type] => 1
[patent_app_number] => 8/024880
[patent_app_country] => US
[patent_app_date] => 1993-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15071
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/296/05296592.pdf
[firstpage_image] =>[orig_patent_app_number] => 024880
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/024880 | Process for purifying interleukin-1 receptors | Feb 28, 1993 | Issued |
| 08/024094 | USE OF RECOMBINANT COLONY STIMULATING FACTOR-1 TO ENHANCE WOUND HEALING | Feb 25, 1993 | Abandoned |
| 08/023146 | METHOD FOR PURIFYING COLONY STIMULATING FACTOR PROTEIN AND SUBSTANTIALLY PURE CSE PROTEIN OBTAINED THEREBY | Feb 23, 1993 | Abandoned |
| 08/017963 | USES OF RECOMBINANT COLONY STIMULATING FACTOR-1 | Feb 11, 1993 | Abandoned |
Array
(
[id] => 3029845
[patent_doc_number] => 05349051
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-09-20
[patent_title] => 'Modified interluekin-1.beta.'
[patent_app_type] => 1
[patent_app_number] => 8/013663
[patent_app_country] => US
[patent_app_date] => 1993-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7899
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/349/05349051.pdf
[firstpage_image] =>[orig_patent_app_number] => 013663
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/013663 | Modified interluekin-1.beta. | Feb 3, 1993 | Issued |
Array
(
[id] => 3427096
[patent_doc_number] => 05462862
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-10-31
[patent_title] => 'Method and compositions for enhancing production of secondary metabolites using clustered biosynthetic genes'
[patent_app_type] => 1
[patent_app_number] => 8/008688
[patent_app_country] => US
[patent_app_date] => 1993-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12624
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/462/05462862.pdf
[firstpage_image] =>[orig_patent_app_number] => 008688
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/008688 | Method and compositions for enhancing production of secondary metabolites using clustered biosynthetic genes | Jan 24, 1993 | Issued |
Array
(
[id] => 2997507
[patent_doc_number] => 05362853
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-11-08
[patent_title] => 'Polypeptide derivatives of human granulocyte colony stimulating factor'
[patent_app_type] => 1
[patent_app_number] => 7/994924
[patent_app_country] => US
[patent_app_date] => 1992-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 36582
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/362/05362853.pdf
[firstpage_image] =>[orig_patent_app_number] => 994924
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/994924 | Polypeptide derivatives of human granulocyte colony stimulating factor | Dec 21, 1992 | Issued |
Array
(
[id] => 3096885
[patent_doc_number] => 05298603
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-03-29
[patent_title] => 'GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use'
[patent_app_type] => 1
[patent_app_number] => 7/993859
[patent_app_country] => US
[patent_app_date] => 1992-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 23
[patent_no_of_words] => 6821
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/298/05298603.pdf
[firstpage_image] =>[orig_patent_app_number] => 993859
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/993859 | GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use | Dec 20, 1992 | Issued |